# Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement

> **NCT00465218** · — · COMPLETED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 56 (actual)

## Conditions studied

- Aortic Valve Disease

## Interventions

- **PROCEDURE:** Prophylaxis of Thrombosis after aortic valve replacement

## Key facts

- **NCT ID:** NCT00465218
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-12
- **Final completion:** 2011-03
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2012-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465218, "Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00465218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*